BME100 f2013:W1200 Group16 L1

BME 100 Fall 2013	Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
OUR TEAM Name: Courtney Willson Role(s) Name: Ayanna Akinyemi Role(s) Name: Rene Reynolds Role(s) Name: John Jakoubek Role(s) Name: Mychal Hooser Role(s) LAB 1 WRITE-UP Independent and Dependent Variables Independent Variable: Amount of lipopolysaccharide Dependent Variable: Level of Inflammotin Experimental Design Groups 6 Number of subjects per group 10 subjects per group Group 1- Placebo (0 mg of LPS) Group 2- 6 mg of LPS Group 3- 8 mg of LPS Group 4- 10 mg of LPS Group 5- 12 mg of LPS Group 6- 14 mg of LPS We chose above and below 10 mg of LPS because some people are more susceptible to change than others 1 dose a day for 30 days Take blood sample twice a week for a month Measure the amount of Inflammotin in the blood via ELISA Compare results of groups 1 though 6. Graph the results of amount of LPS with the amount of Inflammotin in the blood Using the graph, make conclusions about the effect of LPS on the amount of Inflammotin in the blood Subject Selection Age: 2 from 50's, 2 from 60's, 2 from 70's, 2 from 80's, 2 from 90's Gender: 5 Females and 5 Males/Group Weight/Height: 3 from below average weight, 3 from average weight, 4 from above average weight per group Varying health conditions (some might have cancer or be a survivor, some might have heart problems, some might have down syndrome or other mental diseases) Sources of Error and Bias Time of day (Take medication and blood test at the same time of day) - inconsistency in results; allows for more control in data Additional medications (Record any additional medications subjects are taking) - negate or enhance the effect of the drug